Beneath the bonnet: The case for XPS Pensions, TechnoPro and Avidity
Three fund managers share stocks that are making a difference
biotech
-
-
Square Mile: Capital growth funds tussle with income funds for advisers’ attention
Aegon Diversified Monthly Income took the top spot for the most-searched fund
-
Is ‘capital tourism’ an opportunity or a threat for investors?
Non-specialist investors flooding into and out of the latest fashionable investment idea can be as much an opportunity as a threat
-
Covid-driven biotech and healthcare run set to continue for investors with high risk tolerance
Schroder Global Healthcare and Axa Framlinton Health Care have returned 519% and 289% over the past decade
-
Family office firm taps Neil Woodford for unquoted expertise in ‘astonishing’ comeback
‘His ability to pick potential winners ‘off the beaten track’, particularly unquoted companies, is completely unproven’
-
Healthcare fund managers caution against getting caught up in Covid-19 vaccine hype
Gilead Sciences has taken investors on a rollercoaster ride as it trials a treatment for the coronavirus
-
Coronavirus weekly round-up: Gilead drug trial excites markets but US growth falls 4.8%
Five investors mull the events shaping portfolios over the past week
-
Neil Woodford singled out as UK biotech funding falls 40%
Equity manager had wanted to be a champion of UK science before his firm folded
-
Non-execs quietly part ways with Woodford amid wind-down
Woodford provided funding for biotech start-ups backed by adviser and NED Martin Walton
-
Sophie Meatyard: Breaking down the top-performing MSCI sector of 2018
MSCI World Health Care Index reaped positive returns as the wider market sold off
-
Biotech dominates the top five investment trusts of Q3
Stifel data reveals the top investment trusts during Q3 2018
-
Biotech innovation outpaces fund performance
The biotech sector is going through a renaissance as innovation takes off according to one successful fund manager, but data shows that performance over the last three years has been far less than stellar.